Clinical Trial: Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
Study Status: Completed
Recruit Status: RECRUITING
Condition: Breast Cancer Stage III
Study Type: INTERVENTIONAL
Official Title: Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer: Non-randomized Phase II, Prospective Single Arm Study Clinical Trial
Brief Summary:
The purpose of the study is to evaluate treatment outcomes of breast cancer with internal mammary or supraclavicular lymph node metastasis according to total radiation dose of postoperative radiation therapy differentiated by tumor response to neoadjuvant chemotherapy.The main questions it aims to answer are:5-year disease-free survival5-year overall survival5-year locoregional recurrenceAdverse events after radiation therapyQuality of lifeParticipants will be assessed by multi-dimensional methods before and after…
Read more